🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Help Shape the Future of PAH Treatment! Are you a PAH Patient currently on therapy in the Los Angeles area? 📍 In-person focus group in Culver City 📅 Saturday, May 31 🕒 60 minutes 💰 $100 compensation 🍽️ Meal provided 🔗 Learn More: tinyurl.com/2025PAH

Seth Hall, MBA, RRT explores the history, benefits, and future potential of inhaled therapies, with a special focus on emerging technologies. phaware® podcast ep 520 #PHILD Liquidia Corporation #PrintTechnology phawarepodcast.libsyn.com/site/episode-5…

Get Paid $100 to Share Your Experience! PAH patients on inhaled therapy in the LA area: Be part of a 60-min in-person focus group on a new therapy package design. 📅 Saturday, May 31 in Culver City, CA 💰 $100 honorarium 🍽️ Meal provided 🔗 Learn More: tinyurl.com/2025PAH

Get Paid $100 to Share Your PAH Experience! Calling all PAH patients on therapy in the LA area: Be part of a 60-minute in-person focus group on a new therapy package design. 📅 Saturday, May 31 in Culver City, CA 🍽️ Meal provided 🔗 Learn More: tinyurl.com/2025PAH

Dr. Jean Elwing discusses groundbreaking advancements in treating pulmonary hypertension associated with interstitial lung disease. phaware® podcast ep 521 #phawareMD UC Health Jean M. Elwing CHEST Gossamer Bio #Pulmovant #PHOCUSstudy #PROSERAstudy medium.com/p/im-aware-tha…

Dr. Jean Elwing discusses groundbreaking advancements in treating pulmonary hypertension associated with interstitial lung disease. phaware® podcast ep 521 #phawareMD #PHILD UC Health Jean M. Elwing CHEST Gossamer Bio #Pulmovant #ClinicalTrials oembed.libsyn.com/embed?item_id=…

PAH Warriors - Seeking LA area PAH patients currently on inhaled therapy. Join a one hour in-person focus group to review new treatment packaging options. 🗓️ Saturday, May 31 📍 Culver City, CA 💰 $100 honorarium 🍽️ Meal provided 🔗 Sign Up: tinyurl.com/2025PAH

Dr. Jean Elwing discusses groundbreaking advancements in treating pulmonary hypertension associated with interstitial lung disease. phaware® podcast ep 521 #phawareMD #PHILD UC Health Jean M. Elwing CHEST Gossamer Bio #Pulmovant #ClinicalTrials oembed.libsyn.com/embed?item_id=…

Seeking LA area PAH patients currently on therapy. Your insights can help improve care. Join a one hour in-person focus group to review new treatment packaging. 🗓️ Saturday, May 31 📍 Culver City, CA 💰 $100 honorarium 🍽️ Meal provided 🔗 Sign Up: tinyurl.com/2025PAH

YUTREPIA™ is now approved for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) and pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve the ability to exercise. Learn more: liquidia.com/news-releases/…

Are you a PAH Patient currently on inhaled therapy in the LA area? Your opinion on new treatment packaging could help others. 📍 In-person focus group in Culver City 📅 Saturday, May 31 🕒 60 minutes 💰 $100 compensation 🍽️ Meal provided 🔗 Learn More: tinyurl.com/2025PAH

Dr. Marc Simon discusses diagnosing pulmonary hypertension. His insights help clinicians refine their diagnostic approaches for better patient outcomes. phaware® podcast ep 522 #phawareMD #PHILD Liquidia Corporation UCSF Cardiology MarcSimonMD California Thoracic Society medium.com/p/im-aware-tha…

Dr. Marc Simon discusses diagnosing pulmonary hypertension. His insights help clinicians refine their diagnostic approaches for better patient outcomes. phaware® podcast ep 522 #phawareMD #PHILD Liquidia Corporation UCSF Cardiology MarcSimonMD California Thoracic Society ow.ly/2ZaQ50VZg0U

Are you a PAH Patient currently on therapy in the LA area? Your opinion on new treatment packaging could help others like you. 📍 In-person focus group in Culver City 📅 Saturday, May 31 🕒 60 minutes 💰 $100 compensation 🍽️ Meal provided 🔗 Learn More: tinyurl.com/2025PAH

Dr. Rodolfo Estrada discusses the technology and clinical development behind YUTREPIA™ (treprostinil) inhalation powder and why it might be a good option for some PAH and PH-ILD patients. phaware® podcast ep 523 Liquidia Corporation Rodolfo A. Estrada, MD FCCP UT Health San Antonio medium.com/p/im-aware-tha…

Now FDA Approved. YUTREPIA™ (treprostinil) inhalation powder. Learn More: ow.ly/O6N550W3nP3

Dr. Rodolfo Estrada discusses the technology and clinical development behind YUTREPIA™ (treprostinil) inhalation powder and why it might be a good option for some PAH and PH-ILD patients. phaware® podcast ep 523 Liquidia Corporation Rodolfo A. Estrada, MD FCCP UT Health San Antonio ow.ly/YQPO50W3lXb

Real World Data and YOU! Dr. Jason Weatherald explains how your everyday clinic visits can help shape the future of pulmonary hypertension treatment. phaware® podcast ep 524 @phacanada #phawareMD Team PHenomenal Hope Jason Weatherald MD University of Alberta medium.com/p/im-aware-tha…

Dr. Jason Weatherald explains how your everyday clinic visits — from walk tests to how you feel — can help shape the future of pulmonary hypertension treatment. phaware® episode 524 @phacanada #phawareMD Team PHenomenal Hope Jason Weatherald MD University of Alberta ow.ly/tJiG50W6ZuF

Cardiologist Dr. Lisa Mielniczuk on one of the most common — yet misunderstood — forms of pulmonary hypertension: the kind caused by left heart disease. phaware® podcast ep 525 #phawareMD Mayo Clinic PHA Canada @TeamPHHope medium.com/p/im-aware-tha…